CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4,268 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01547884
NCT01547884N/ACompleted

Effect of Filarial Infection on Antigen-Specific Immune Responses in Latent Tuberculosis

National Institute of Allergy and Infectious Diseases (NIAID)·observational·Posted Mar 8, 2012·Updated Apr 20, 2021

In Brief

An observational study for Mycobacterium Infections and 3 related conditions. Completed, enrolled 4,268 participants across 2 sites in 2 countries.

Detailed Summary

Background: \- Lymphatic filariasis is an infection that is caused by small, thread-like worms. It is spread by mosquitoes, and causes fever, chills, and headaches. If untreated, it can also cause elephantiasis, a condition that leads to swelling of the arms, legs, breasts, and scrotum. Treatment can eliminate the worms from the blood and reduce the risk of developing elephantiasis. Researchers want to study people with latent tuberculosis (TB) who may or may not be infected with filariasis. This study will look at the way that people with latent TB fight infection with these worms. Objectives: \- To study how the immune systems of people with latent TB react to filarial infection. Eligibility: \- Individuals between 18 and 65 years of age who have latent TB and may or may not have filarial infection. Design: * Participants will be screened with a physical exam and medical history. They will provide a blood and stool sample to test for infection. * Participants who do not have lymphatic filariasis but have another kind of intestinal worm will be treated for the parasite. This will be their last study visit. * Participants who have latent TB and lymphatic filariasis will be treated with the standard treatment for the disease. They will come back for a second visit 6 months later, and will provide another blood sample.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesIndia, United States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 8, 2012
Enrollment StartJan 1, 2013
Primary CompletionNov 14, 2019
Study CompletionAug 7, 2020
TodayJul 2, 2026
Enrollment to primary: 6.9 yearsPosted 14.3 years ago